Genvor Inc

2022 Q2 Form 10-Q Financial Statement

#000147793222002633 Filed on April 27, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q3

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $435.4K $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00 $3.393K
Receivables
Other Receivables
Total Short-Term Assets $435.4K $225.7K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $18.02K $19.40K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $20.02K $21.40K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $435.4K $225.7K
Total Long-Term Assets $20.02K $21.40K
Total Assets $455.4K $0.00 $247.1K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.36K $5.500K $33.32K
YoY Change 344.25%
Accrued Expenses $34.97K $122.2K
YoY Change 1936.27%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.553M $42.87K $2.248M
YoY Change 40273.19% 12860.08%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.553M $42.87K $2.248M
Total Long-Term Liabilities
Total Liabilities $1.865M $2.738M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$15.78M -$79.74K -$11.31M
YoY Change 38645.73%
Common Stock $285.00 $20.00K $24.51K
YoY Change -98.58% -78.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.410M -$42.87K -$2.491M
YoY Change
Total Liabilities & Shareholders Equity $455.4K $0.00 $247.1K
YoY Change

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Assets
Assets
0 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5500 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
16239 USD
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
33526 USD
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20000000 shares
CY2022Q1 us-gaap Assets
Assets
0 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7585 USD
CY2022Q1 allure Related Party Transactions Due From To Related Party
RelatedPartyTransactionsDueFromToRelatedParty
3846 USD
CY2021Q3 allure Related Party Transactions Due From To Related Party
RelatedPartyTransactionsDueFromToRelatedParty
3846 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
42872 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27670 USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20000000 shares
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2022Q1 us-gaap Revenues
Revenues
0 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2021Q1 us-gaap Revenues
Revenues
0 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10000 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15202 USD
us-gaap Revenues
Revenues
0 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
10000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
0 USD
us-gaap Operating Expenses
OperatingExpenses
15202 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-10000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16870 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-64540 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-27670 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
16870 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79742 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-42872 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-15202 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 USD
us-gaap Operating Expenses
OperatingExpenses
0 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-3846 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-27670 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
0 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
us-gaap Net Income Loss
NetIncomeLoss
0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Net Income Loss
NetIncomeLoss
0 USD
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-15846 USD
allure Accrued Expenses Paid By Shareholder
AccruedExpensesPaidByShareholder
6000 USD
us-gaap Net Income Loss
NetIncomeLoss
-15202 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-42872 USD
us-gaap Net Income Loss
NetIncomeLoss
-15202 USD
us-gaap Net Income Loss
NetIncomeLoss
0 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
17287 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2085 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
allure Capital Contribution From Shareholder To Pay Accrued Expenses
CapitalContributionFromShareholderToPayAccruedExpenses
0 USD
allure Capital Contribution From Shareholder To Pay Accrued Expenses
CapitalContributionFromShareholderToPayAccruedExpenses
13500 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79742 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.001
us-gaap Net Income Loss
NetIncomeLoss
-15202 USD
us-gaap Net Income Loss
NetIncomeLoss
0 USD
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
14900 USD
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11200 USD
allure Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1
0.25 pure
CY2022Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
19705 USD
us-gaap Premiums Percentage Assumed To Net
PremiumsPercentageAssumedToNet
0.10 pure
us-gaap Debt Instrument Term
DebtInstrumentTerm
P18M

Files In Submission

Name View Source Status
0001477932-22-002633-index-headers.html Edgar Link pending
0001477932-22-002633-index.html Edgar Link pending
0001477932-22-002633.txt Edgar Link pending
0001477932-22-002633-xbrl.zip Edgar Link pending
allure-20220331.xsd Edgar Link pending
allure-20220331_cal.xml Edgar Link unprocessable
allure-20220331_def.xml Edgar Link unprocessable
allure-20220331_lab.xml Edgar Link unprocessable
allure-20220331_pre.xml Edgar Link unprocessable
allure_10q.htm Edgar Link pending
allure_10q_htm.xml Edgar Link completed
allure_ex311.htm Edgar Link pending
allure_ex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending